Mechanisms of MYC stabilization in human malignancies

128Citations
Citations of this article
90Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

MYC is a pleiotropic transcription factor that has been linked to a diverse range of cellular functions, such as cell cycle regulation, proliferation, growth, differentiation and metabolism. Not surprisingly, aberrant MYC signaling has been observed in human cancers and MYC has been demonstrated to promote cell transformation and tumor progression. Here we discuss recent discoveries that have expanded our knowledge of MYC protein stability. In particular we focus on mechanisms that might explain the increased stability of MYC often observed in human cancers and cell lines. We also summarize our recent characterization of Cancerous inhibitor of PP2A (CIP2A/KIAA1524) as a protein that inhibits PP2A-mediated MYC dephosphorylation and proteolytic degradation. Finally, we discuss the potential relevance of mechanisms that regulate MYC stability for tumor formation in the context of cancer therapy. ©2008 Landes Bioscience.

Cite

CITATION STYLE

APA

Junttila, M. R., & Westermarck, J. (2008, March 1). Mechanisms of MYC stabilization in human malignancies. Cell Cycle. Taylor and Francis Inc. https://doi.org/10.4161/cc.7.5.5492

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free